(Q52852275)

8 May 2018

title

Atherosclerosis in primary antiphospholipid syndrome. (English)

1 reference

8 May 2018

1 reference

6

Eiji Matsuura

1 reference

8 May 2018

Paul R J Ames

1

1 reference

8 May 2018

Giovanna Scenna

2

1 reference

8 May 2018

Iolanda Antinolfi

3

1 reference

8 May 2018

Luis Lopez

4

1 reference

8 May 2018

Luigi Iannaccone

5

1 reference

8 May 2018

Annamaria Margarita

7

1 reference

8 May 2018

publication date

1 January 2008

1 reference

8 May 2018

Expert Review of Clinical Immunology

published in

1 reference

8 May 2018

volume

4

1 reference

8 May 2018

issue

1

1 reference

8 May 2018

page(s)

53-60

1 reference

8 May 2018

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

cites work

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Antiphospholipid antibodies in vascular surgery patients. A cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

The prevalence of thrombophilia in patients with symptomatic peripheral vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Massive lower extremity arterial thrombosis and acute hepatic insufficiency in a young adult with premature atherosclerosis associated with hyperlipoprotein(a)emia and antiphospholipid syndrome. A case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Severe atherosclerotic changes, including aortic occlusion, associated with hyperhomocysteinaemia and antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Subclinical atherosclerosis in primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome: preliminary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Endothelial function is impaired in patients with primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Inflammatory response and the endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Nailfold videocapillaroscopy in primary antiphospholipid syndrome (PAPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Vasculopathy and arterial stenotic lesions in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Novel expression of VCAM-1 on the mitral valve in a patient with primary antiphospholipid antibody syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

The Framingham Risk Score: an appraisal of its benefits and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Overview of hemostatic factors involved in atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Urinary 8-epi-PGF2alpha and its endogenous beta-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Atherosclerosis and oxidant stress: the end of the road for antioxidant vitamin treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

NF-kappaB activation by reactive oxygen species: fifteen years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-inflammatory phenotype in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Increased lipid peroxidation correlates with platelet activation but not with markers of endothelial cell and blood coagulation activation in patients with antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Oxidized low-density lipoprotein biomarkers in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Antibodies against beta2-glycoprotein I complexed with an oxidised lipoprotein relate to intima thickening of carotid arteries in primary antiphospholipid syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Scavenger cell receptor shared.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Apolipoprotein A-I and risk for cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Antibodies toward high-density lipoprotein components inhibit paraoxonase activity in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Statins and the vascular endothelial inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Aspirin inhibits endothelial cell activation induced by antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Endothelin-1 gene expression in endothelial cells is potently inhibited by a vasodilator, dilazep

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.1.53

21 January 2018

Identifiers

DOI

10.1586/1744666X.4.1.53

1 reference

8 May 2018

1 reference

8 May 2018